IRIS Accounts Production v25.2.0.378 04331554 Board of Directors 31.12.24 1.1.24 31.12.24 31.12.24 Medium entities These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. a plant nursery. true true true false true true false false false false true false Fair value model Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh043315542023-12-31043315542024-12-31043315542024-01-012024-12-31043315542022-12-31043315542023-01-012023-12-31043315542023-12-3104331554ns15:EnglandWales2024-01-012024-12-3104331554ns14:PoundSterling2024-01-012024-12-3104331554ns10:Director12024-01-012024-12-3104331554ns10:Consolidated2024-12-3104331554ns10:ConsolidatedGroupCompanyAccounts2024-01-012024-12-3104331554ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3104331554ns10:Consolidatedns10:MediumEntities2024-01-012024-12-3104331554ns10:Consolidatedns10:Audited2024-01-012024-12-3104331554ns10:Medium-sizedCompaniesRegimeForDirectorsReport2024-01-012024-12-3104331554ns10:Medium-sizedCompaniesRegimeForAccounts2024-01-012024-12-3104331554ns10:Consolidated2024-01-012024-12-3104331554ns10:Consolidatedns10:Medium-sizedCompaniesRegimeForDirectorsReport2024-01-012024-12-3104331554ns10:Medium-sizedCompaniesRegimeForAccountsns10:Consolidated2024-01-012024-12-3104331554ns10:FullAccounts2024-01-012024-12-3104331554ns5:Subsidiary12024-01-012024-12-310433155412024-01-012024-12-3104331554ns10:OrdinaryShareClass12024-01-012024-12-3104331554ns10:Director22024-01-012024-12-3104331554ns10:Director32024-01-012024-12-3104331554ns10:Director42024-01-012024-12-3104331554ns10:CompanySecretary12024-01-012024-12-3104331554ns10:RegisteredOffice2024-01-012024-12-3104331554ns10:Consolidated2023-01-012023-12-3104331554ns5:CurrentFinancialInstruments2024-12-3104331554ns5:CurrentFinancialInstruments2023-12-3104331554ns5:Non-currentFinancialInstruments2024-12-3104331554ns5:Non-currentFinancialInstruments2023-12-3104331554ns5:ShareCapital2024-12-3104331554ns5:ShareCapital2023-12-3104331554ns5:RetainedEarningsAccumulatedLosses2024-12-3104331554ns5:RetainedEarningsAccumulatedLosses2023-12-3104331554ns5:ShareCapital2022-12-3104331554ns5:RetainedEarningsAccumulatedLosses2022-12-3104331554ns5:RetainedEarningsAccumulatedLosses2023-01-012023-12-3104331554ns5:RetainedEarningsAccumulatedLosses2024-01-012024-12-3104331554ns5:NetGoodwill2024-01-012024-12-3104331554ns5:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3104331554ns5:PatentsTrademarksLicencesConcessionsSimilar2024-01-012024-12-3104331554ns5:OwnedOrFreeholdAssetsns5:LandBuildings2024-01-012024-12-3104331554ns5:PlantMachinery2024-01-012024-12-3104331554ns5:FurnitureFittings2024-01-012024-12-3104331554ns5:MotorVehicles2024-01-012024-12-3104331554ns5:NetGoodwill2024-12-3104331554ns5:PatentsTrademarksLicencesConcessionsSimilar2024-12-3104331554ns5:LandBuildings2023-12-3104331554ns5:PlantMachinery2023-12-3104331554ns5:FurnitureFittings2023-12-3104331554ns5:LandBuildings2024-01-012024-12-3104331554ns5:LandBuildings2024-12-3104331554ns5:PlantMachinery2024-12-3104331554ns5:FurnitureFittings2024-12-3104331554ns5:LandBuildings2023-12-3104331554ns5:PlantMachinery2023-12-3104331554ns5:FurnitureFittings2023-12-3104331554ns5:MotorVehicles2023-12-3104331554ns5:ComputerEquipment2023-12-3104331554ns5:ComputerEquipment2024-01-012024-12-3104331554ns5:MotorVehicles2024-12-3104331554ns5:ComputerEquipment2024-12-3104331554ns5:MotorVehicles2023-12-3104331554ns5:ComputerEquipment2023-12-3104331554ns5:LeasedAssetsHeldAsLesseens5:PlantMachinery2023-12-3104331554ns5:LeasedAssetsHeldAsLesseens5:PlantMachinery2024-01-012024-12-3104331554ns5:LeasedAssetsHeldAsLesseens5:PlantMachinery2024-12-3104331554ns5:LeasedAssetsHeldAsLesseens5:PlantMachinery2023-12-3104331554ns5:CostValuation2023-12-3104331554ns5:CostValuationns5:UnlistedNon-exchangeTraded2023-12-3104331554ns5:UnlistedNon-exchangeTraded2024-12-3104331554ns5:UnlistedNon-exchangeTraded2023-12-31043315541ns5:Subsidiary12024-01-012024-12-3104331554ns5:Subsidiary12024-12-3104331554ns5:Subsidiary12023-12-3104331554ns5:Subsidiary12023-01-012023-12-3104331554ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3104331554ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-3104331554ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2023-12-3104331554ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2024-12-3104331554ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-12-3104331554ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-12-3104331554ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2024-12-3104331554ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2023-12-3104331554ns5:HirePurchaseContractsns5:BetweenOneFiveYears2024-12-3104331554ns5:HirePurchaseContractsns5:BetweenOneFiveYears2023-12-3104331554ns5:HirePurchaseContracts2024-12-3104331554ns5:HirePurchaseContracts2023-12-3104331554ns5:WithinOneYear2024-12-3104331554ns5:WithinOneYear2023-12-3104331554ns5:BetweenOneFiveYears2024-12-3104331554ns5:BetweenOneFiveYears2023-12-3104331554ns5:AllPeriods2024-12-3104331554ns5:AllPeriods2023-12-3104331554ns5:Secured2024-12-3104331554ns5:Secured2023-12-3104331554ns5:DeferredTaxation2023-12-3104331554ns5:DeferredTaxation2024-01-012024-12-3104331554ns5:DeferredTaxation2024-12-3104331554ns10:OrdinaryShareClass12024-12-3104331554ns5:RetainedEarningsAccumulatedLosses2023-12-31
REGISTERED NUMBER: 04331554 (England and Wales)












BELL BROTHERS NURSERIES LIMITED

GROUP STRATEGIC REPORT,

REPORT OF THE DIRECTORS AND

CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024






BELL BROTHERS NURSERIES LIMITED (REGISTERED NUMBER: 04331554)

CONTENTS OF THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024










Page

Company Information 1

Group Strategic Report 2

Report of the Directors 3

Report of the Independent Auditors 5

Consolidated Income Statement 8

Consolidated Other Comprehensive Income 9

Consolidated Balance Sheet 10

Company Balance Sheet 11

Consolidated Statement of Changes in Equity 12

Company Statement of Changes in Equity 13

Consolidated Cash Flow Statement 14

Notes to the Consolidated Cash Flow Statement 15

Notes to the Consolidated Financial Statements 17


BELL BROTHERS NURSERIES LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2024







DIRECTORS: B D Bell
Mrs M A Bell
R A Bell
Mr J D Bell





SECRETARY: Mrs M A Bell





REGISTERED OFFICE: The Old Vicarage
Church Close
Boston
Lincolnshire
PE21 6NA





REGISTERED NUMBER: 04331554 (England and Wales)





AUDITORS: Dexter & Sharpe
Chartered Certified Accountants
& Registered Auditors
The Old Vicarage
Church Close
Boston
Lincolnshire
PE21 6NA

BELL BROTHERS NURSERIES LIMITED (REGISTERED NUMBER: 04331554)

GROUP STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024


The directors present their strategic report of the company and the group for the year ended 31 December 2024.

The principal activity of the group in the year under review was that of nursery men and farming.

REVIEW OF BUSINESS
Turnover increased by 15% compared to prior year reflecting the purchase of Peter Beales Roses in February 2024.

The business environment remains highly competitive with pressure on selling prices influencing the margin achieved.

The company will continue to concentrate on the higher margin products and continue its efficiency plans.

PRINCIPAL RISKS AND UNCERTAINTIES
The Group operates in a challenging economic climate. As such management of the group's business and the execution of the group's strategies are subject to a number of risks:

- Impact of weather on production and supply costs and on customer demand;
- The strength local, national and international competition;
- The risks associated with needing to hold a wide range of stock lines to satisfy customer requirements.


The controllable risks are being addressed by continued focus on stock management processes and production efficiencies.

The group uses various financial instruments including cash, overdraft facilities, loans, HP finance and such items such as trade creditors that arise directly from its operations, the main purpose of which is to ensure liquidity of the group's activities.

The main risks arising from the Group's financial instruments and the management of these risks are summarised below:

- Credit risk. Credit checks and credit limits and follow up of overdue debts;

- Liquidity risks. The group manages its financial risks by ensuring that there is enough liquidity to meet its short and long term requirements, principally through bank loans and overdraft facilities:

- Interest rate risk. The company is exposed to a rise in interest rates. However, management anticipate that its operating result would cover any likely interest increase;

- Currency risks. The company is exposed to the Euro and US $. Forward contracts are taken out from time to time to manage these risks.

KEY PERFORMANCE INDICATORS
We consider the key performance indicators to be measured by turnover, operating profit as a percentage of turnover and operating cash inflow.

ON BEHALF OF THE BOARD:





R A Bell - Director


29 September 2025

BELL BROTHERS NURSERIES LIMITED (REGISTERED NUMBER: 04331554)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 31 DECEMBER 2024


The directors present their report with the financial statements of the company and the group for the year ended 31 December 2024.

DIVIDENDS
No dividends will be distributed for the year ended 31 December 2024.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 January 2024 to the date of this report.

B D Bell
Mrs M A Bell
R A Bell
Mr J D Bell

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Group Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the group and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:

- select suitable accounting policies and then apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's and the group's transactions and disclose with reasonable accuracy at any time the financial position of the company and the group and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the group's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the group's auditors are aware of that information.

BELL BROTHERS NURSERIES LIMITED (REGISTERED NUMBER: 04331554)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 31 DECEMBER 2024


AUDITORS
The auditors, Dexter & Sharpe, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:




R A Bell - Director


29 September 2025

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
BELL BROTHERS NURSERIES LIMITED


Opinion
We have audited the financial statements of Bell Brothers Nurseries Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 December 2024 which comprise the Consolidated Income Statement, Consolidated Other Comprehensive Income, Consolidated Balance Sheet, Company Balance Sheet, Consolidated Statement of Changes in Equity, Company Statement of Changes in Equity, Consolidated Cash Flow Statement and Notes to the Consolidated Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the group's and of the parent company affairs as at 31 December 2024 and of the group's loss for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and the parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Group Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
BELL BROTHERS NURSERIES LIMITED


Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Group Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Group Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception
In the light of the knowledge and understanding of the group and the parent company and its environment obtained in the course of the audit, we have not identified material misstatements in the Group Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or
- the parent company financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page three, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the group's and the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the group or the parent company or to cease operations, or have no realistic alternative but to do so.

Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

We have enquired of those charged with governance around actual and potential litigation and claims.

We have reviewed financial statement disclosures and testing to supporting documentation to assess compliance with applicable laws and regulations.

Enquired of staff engaged in the completion of VAT, tax and compliance work to identify any instances of non compliance with laws and regulations.

Audited the risk of management override of controls including review of journal entries and large or unusual transaction, evaluating the business rationale of any significant transactions outside the course of business.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
BELL BROTHERS NURSERIES LIMITED





Mrs Nicola Michelle Lenton FCCA (Senior Statutory Auditor)
for and on behalf of Dexter & Sharpe
Chartered Certified Accountants
& Registered Auditors
The Old Vicarage
Church Close
Boston
Lincolnshire
PE21 6NA

29 September 2025

BELL BROTHERS NURSERIES LIMITED (REGISTERED NUMBER: 04331554)

CONSOLIDATED
INCOME STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2024

2024 2023
Notes £    £   

TURNOVER 11,096,783 9,603,737

Cost of sales (6,106,105 ) (6,714,699 )
GROSS PROFIT 4,990,678 2,889,038

Distribution costs (770,338 ) (613,789 )
Administrative expenses (4,888,334 ) (2,996,224 )
(667,994 ) (720,975 )

Other operating income 589,567 1,164,154
OPERATING (LOSS)/PROFIT 3 (78,427 ) 443,179

Interest receivable and similar income 12 2,699
(78,415 ) 445,878

Interest payable and similar expenses 4 (384,232 ) (249,396 )
(LOSS)/PROFIT BEFORE TAXATION (462,647 ) 196,482

Tax on (loss)/profit 5 (50,823 ) (105,503 )
(LOSS)/PROFIT FOR THE FINANCIAL
YEAR

(513,470

)

90,979
(Loss)/profit attributable to:
Owners of the parent (507,196 ) 95,713
Non-controlling interests (6,274 ) (4,734 )
(513,470 ) 90,979

BELL BROTHERS NURSERIES LIMITED (REGISTERED NUMBER: 04331554)

CONSOLIDATED
OTHER COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2024

2024 2023
Notes £    £   

(LOSS)/PROFIT FOR THE YEAR (513,470 ) 90,979


OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME FOR
THE YEAR

(513,470

)

90,979

Total comprehensive income attributable to:
Owners of the parent (507,196 ) 95,712
Non-controlling interests (6,274 ) (4,733 )
(513,470 ) 90,979

BELL BROTHERS NURSERIES LIMITED (REGISTERED NUMBER: 04331554)

CONSOLIDATED BALANCE SHEET
31 DECEMBER 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 7 466,450 -
Tangible assets 8 3,105,486 2,365,833
Investments 9 3,001 3,001
Investment property 10 300,000 -
3,874,937 2,368,834

CURRENT ASSETS
Stocks 11 3,783,284 2,505,528
Debtors: amounts falling due within one year 12 1,429,106 2,704,953
Cash at bank and in hand 32,363 35,809
5,244,753 5,246,290
CREDITORS
Amounts falling due within one year 13 3,782,289 2,633,461
NET CURRENT ASSETS 1,462,464 2,612,829
TOTAL ASSETS LESS CURRENT
LIABILITIES

5,337,401

4,981,663

CREDITORS
Amounts falling due after more than one year 14 (3,189,469 ) (2,365,057 )

PROVISIONS FOR LIABILITIES 18 (150,300 ) (105,503 )
NET ASSETS 1,997,632 2,511,103

CAPITAL AND RESERVES
Called up share capital 19 1,000 1,000
Retained earnings 20 2,002,888 2,510,084
SHAREHOLDERS' FUNDS 2,003,888 2,511,084

NON-CONTROLLING INTERESTS 21 (6,256 ) 19
TOTAL EQUITY 1,997,632 2,511,103

The financial statements were approved by the Board of Directors and authorised for issue on 29 September 2025 and were signed on its behalf by:



R A Bell - Director


BELL BROTHERS NURSERIES LIMITED (REGISTERED NUMBER: 04331554)

COMPANY BALANCE SHEET
31 DECEMBER 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 7 466,450 -
Tangible assets 8 2,561,902 1,819,832
Investments 9 3,901 3,901
Investment property 10 300,000 -
3,332,253 1,823,733

CURRENT ASSETS
Stocks 11 3,778,762 2,498,684
Debtors: amounts falling due within one year 12 1,970,171 3,239,715
Cash at bank and in hand 27,859 30,842
5,776,792 5,769,241
CREDITORS
Amounts falling due within one year 13 3,708,651 2,611,062
NET CURRENT ASSETS 2,068,141 3,158,179
TOTAL ASSETS LESS CURRENT
LIABILITIES

5,400,394

4,981,912

CREDITORS
Amounts falling due after more than one year 14 (3,189,469 ) (2,365,057 )

PROVISIONS FOR LIABILITIES 18 (150,300 ) (105,503 )
NET ASSETS 2,060,625 2,511,352

CAPITAL AND RESERVES
Called up share capital 19 1,000 1,000
Retained earnings 20 2,059,625 2,510,352
SHAREHOLDERS' FUNDS 2,060,625 2,511,352

Company's (loss)/profit for the financial year (450,727 ) 138,315

The financial statements were approved by the Board of Directors and authorised for issue on 29 September 2025 and were signed on its behalf by:




R A Bell - Director


BELL BROTHERS NURSERIES LIMITED (REGISTERED NUMBER: 04331554)

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024

Called up
share Retained Non-controlling Total
capital earnings Total interests equity
£    £    £    £    £   
Balance at 1 January 2023 1,000 2,414,371 2,415,371 4,752 2,420,123

Changes in equity
Total comprehensive income - 95,713 95,713 (4,733 ) 90,980
Balance at 31 December 2023 1,000 2,510,084 2,511,084 19 2,511,103

Changes in equity
Total comprehensive income - (507,196 ) (507,196 ) (6,274 ) (513,470 )
Balance at 31 December 2024 1,000 2,002,888 2,003,888 (6,255 ) 1,997,633

BELL BROTHERS NURSERIES LIMITED (REGISTERED NUMBER: 04331554)

COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024

Called up
share Retained Total
capital earnings equity
£    £    £   
Balance at 1 January 2023 1,000 2,372,037 2,373,037

Changes in equity
Total comprehensive income - 138,315 138,315
Balance at 31 December 2023 1,000 2,510,352 2,511,352

Changes in equity
Total comprehensive income - (450,727 ) (450,727 )
Balance at 31 December 2024 1,000 2,059,625 2,060,625

BELL BROTHERS NURSERIES LIMITED (REGISTERED NUMBER: 04331554)

CONSOLIDATED CASH FLOW STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2024

2024 2023
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 586,147 219,566
Interest paid (365,521 ) (236,870 )
Interest element of hire purchase payments paid (18,711 ) (12,526 )
Tax paid 6,038 126,689
Net cash from operating activities 207,953 96,859

Cash flows from investing activities
Purchase of intangible fixed assets (491,000 ) -
Purchase of tangible fixed assets (1,044,683 ) (438,463 )
Purchase of investment property (300,000 ) -
Sale of tangible fixed assets 32,064 53,624
Interest received 12 2,699
Net cash from investing activities (1,803,607 ) (382,140 )

Cash flows from financing activities
New loans in year 1,600,000 (220,390 )
Loan repayments in year (537,810 ) 408,970
Capital repayments in year (62,223 ) 83,090
Amount introduced by directors 134,470 300,294
Amount withdrawn by directors (352,204 ) (223,592 )
Net cash from financing activities 782,233 348,372

(Decrease)/increase in cash and cash equivalents (813,421 ) 63,091
Cash and cash equivalents at beginning of
year

2

(519,380

)

(582,471

)

Cash and cash equivalents at end of year 2 (1,332,801 ) (519,380 )

BELL BROTHERS NURSERIES LIMITED (REGISTERED NUMBER: 04331554)

NOTES TO THE CONSOLIDATED CASH FLOW STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2024


1. RECONCILIATION OF (LOSS)/PROFIT BEFORE TAXATION TO CASH GENERATED FROM
OPERATIONS

2024 2023
£    £   
(Loss)/profit before taxation (462,647 ) 196,482
Depreciation charges 317,591 216,173
Profit on disposal of fixed assets (20,074 ) (22,972 )
Finance costs 384,232 249,396
Finance income (12 ) (2,699 )
219,090 636,380
(Increase)/decrease in stocks (1,277,756 ) 585,925
Decrease/(increase) in trade and other debtors 1,416,220 (1,214,957 )
Increase in trade and other creditors 228,593 212,218
Cash generated from operations 586,147 219,566

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 31 December 2024
31.12.24 1.1.24
£    £   
Cash and cash equivalents 32,363 35,809
Bank overdrafts (1,365,164 ) (555,189 )
(1,332,801 ) (519,380 )
Year ended 31 December 2023
31.12.23 1.1.23
£    £   
Cash and cash equivalents 35,809 21,741
Bank overdrafts (555,189 ) (604,212 )
(519,380 ) (582,471 )


BELL BROTHERS NURSERIES LIMITED (REGISTERED NUMBER: 04331554)

NOTES TO THE CONSOLIDATED CASH FLOW STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2024


3. ANALYSIS OF CHANGES IN NET DEBT

At 1.1.24 Cash flow At 31.12.24
£    £    £   
Net cash
Cash at bank and in hand 35,809 (3,446 ) 32,363
Bank overdrafts (555,189 ) (809,975 ) (1,365,164 )
(519,380 ) (813,421 ) (1,332,801 )
Debt
Finance leases (311,794 ) 62,223 (249,571 )
Debts falling due within 1 year (258,936 ) (185,904 ) (444,840 )
Debts falling due after 1 year (2,153,889 ) (876,288 ) (3,030,177 )
(2,724,619 ) (999,969 ) (3,724,588 )
Total (3,243,999 ) (1,813,390 ) (5,057,389 )

BELL BROTHERS NURSERIES LIMITED (REGISTERED NUMBER: 04331554)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024


1. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Basis of consolidation
The Group consolidated financial statements include the financial statements of the Company and of its subsidiary undertaking made up to 31 December 2023.

Significant judgements and estimates
Estimates and judgements are continually evaluated and are based on historical experience and other factors including expectations of future events that are believed to be reasonable under the circumstances.

Stock valuation
The stock valuation is based on costing data. At the direct cost level little judgement is involved. The inclusion and apportionment of production overheads is based on reasonable criteria, but requires an element of judgement.

Useful economic lives of tangible assets
Plant and Machinery, Fixtures and Fittings, and Motor Vehicles are depreciated on a reducing balance method at rates which historically have resulted in a reasonable residual value of the assets. Farm buildings and glasshouses are individually assessed and a straight line or reducing balance method at a rate judged suitable for the particular asset applied. The useful economic lives and residual values are re-assessed annually.

Deferred taxation
Deferred taxation is calculated at the enacted tax rates when the taxation timing differences are expected to reverse. Estimates and judgements are required in making these forecasts.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2024, is being amortised evenly over its estimated useful life of twenty years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of twenty years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Freehold property - 5-15% reducing balance/10% straight line
Plant and machinery - 15% on reducing balance
Fixtures and fittings - 15% on reducing balance
Motor vehicles - 25% on reducing balance

BELL BROTHERS NURSERIES LIMITED (REGISTERED NUMBER: 04331554)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


1. ACCOUNTING POLICIES - continued

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Consolidated Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The group operates a defined contribution pension scheme. Contributions payable to the group's pension scheme are charged to profit or loss in the period to which they relate.

BELL BROTHERS NURSERIES LIMITED (REGISTERED NUMBER: 04331554)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


1. ACCOUNTING POLICIES - continued

Financial instruments
Derivatives are initially recognised at fair value on the date the derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of the derivatives are recognised in profit or loss in finance costs or income as appropriate.

2. EMPLOYEES AND DIRECTORS
2024 2023
£    £   
Wages and salaries 4,454,427 3,593,777
Social security costs 244,948 171,304
Other pension costs 54,872 46,687
4,754,247 3,811,768

The average number of employees during the year was as follows:
2024 2023

Directors 4 4
Managers 15 6
Administration 5 4
Operatives 86 53
110 67

2024 2023
£    £   
Directors' remuneration 82,792 82,160

3. OPERATING (LOSS)/PROFIT

The operating loss (2023 - operating profit) is stated after charging/(crediting):

2024 2023
£    £   
Other operating leases 302,262 193,304
Depreciation - owned assets 235,373 159,255
Depreciation - assets on hire purchase contracts 57,667 56,918
Profit on disposal of fixed assets (20,074 ) (22,972 )
Goodwill amortisation 12,050 -
Patents and licences amortisation 12,500 -
Auditors' remuneration 7,150 7,150
Foreign exchange differences 51 11,048

BELL BROTHERS NURSERIES LIMITED (REGISTERED NUMBER: 04331554)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


4. INTEREST PAYABLE AND SIMILAR EXPENSES
2024 2023
£    £   
Bank interest payable 105,340 66,518
Corporation tax interest 339 199
PAYE/NIC interest 12 -
Loan and mortgage interest
payable 259,830 170,153
Hire purchase and finance lease charges 18,711 12,526
384,232 249,396

5. TAXATION

Analysis of the tax charge
The tax charge on the loss for the year was as follows:
2024 2023
£    £   
Current tax:
Under / (Overprovision) in
previous year 6,026 -

Deferred tax 44,797 105,503
Tax on (loss)/profit 50,823 105,503

6. INDIVIDUAL INCOME STATEMENT

As permitted by Section 408 of the Companies Act 2006, the Income Statement of the parent company is not presented as part of these financial statements.


BELL BROTHERS NURSERIES LIMITED (REGISTERED NUMBER: 04331554)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


7. INTANGIBLE FIXED ASSETS

Group
Patents
and
Goodwill licences Totals
£    £    £   
COST
Additions 241,000 250,000 491,000
At 31 December 2024 241,000 250,000 491,000
AMORTISATION
Amortisation for year 12,050 12,500 24,550
At 31 December 2024 12,050 12,500 24,550
NET BOOK VALUE
At 31 December 2024 228,950 237,500 466,450

Company
Patents
and
Goodwill licences Totals
£    £    £   
COST
Additions 241,000 250,000 491,000
At 31 December 2024 241,000 250,000 491,000
AMORTISATION
Amortisation for year 12,050 12,500 24,550
At 31 December 2024 12,050 12,500 24,550
NET BOOK VALUE
At 31 December 2024 228,950 237,500 466,450

BELL BROTHERS NURSERIES LIMITED (REGISTERED NUMBER: 04331554)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


8. TANGIBLE FIXED ASSETS

Group
Fixtures
Freehold Plant and and
property machinery fittings
£    £    £   
COST
At 1 January 2024 3,320,595 2,498,136 348,594
Additions 672,844 256,508 76,912
Disposals - (37,700 ) -
At 31 December 2024 3,993,439 2,716,944 425,506
DEPRECIATION
At 1 January 2024 2,406,997 1,444,938 292,421
Charge for year 85,783 175,949 16,773
Eliminated on disposal - (28,501 ) -
At 31 December 2024 2,492,780 1,592,386 309,194
NET BOOK VALUE
At 31 December 2024 1,500,659 1,124,558 116,312
At 31 December 2023 913,598 1,053,198 56,173

Motor
vehicles Land Totals
£    £    £   
COST
At 1 January 2024 270,851 311,035 6,749,211
Additions 38,419 - 1,044,683
Disposals (73,329 ) - (111,029 )
At 31 December 2024 235,941 311,035 7,682,865
DEPRECIATION
At 1 January 2024 239,022 - 4,383,378
Charge for year 14,535 - 293,040
Eliminated on disposal (70,538 ) - (99,039 )
At 31 December 2024 183,019 - 4,577,379
NET BOOK VALUE
At 31 December 2024 52,922 311,035 3,105,486
At 31 December 2023 31,829 311,035 2,365,833

BELL BROTHERS NURSERIES LIMITED (REGISTERED NUMBER: 04331554)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


8. TANGIBLE FIXED ASSETS - continued

Group

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:
Plant and
machinery
£   
COST
At 1 January 2024 555,810
Additions 7,503
Transfer to ownership (90,000 )
Reclassification/transfer 552
At 31 December 2024 473,865
DEPRECIATION
At 1 January 2024 107,993
Charge for year 57,667
Transfer to ownership (25,788 )
Reclassification/transfer 21
At 31 December 2024 139,893
NET BOOK VALUE
At 31 December 2024 333,972
At 31 December 2023 447,817

BELL BROTHERS NURSERIES LIMITED (REGISTERED NUMBER: 04331554)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


8. TANGIBLE FIXED ASSETS - continued

Company
Fixtures
Freehold Plant and and
property machinery fittings
£    £    £   
COST
At 1 January 2024 2,790,701 2,447,666 348,594
Additions 672,845 256,508 76,912
Disposals - (37,700 ) -
At 31 December 2024 3,463,546 2,666,474 425,506
DEPRECIATION
At 1 January 2024 2,406,997 1,410,575 292,421
Charge for year 85,783 173,533 16,773
Eliminated on disposal - (28,501 ) -
At 31 December 2024 2,492,780 1,555,607 309,194
NET BOOK VALUE
At 31 December 2024 970,766 1,110,867 116,312
At 31 December 2023 383,704 1,037,091 56,173

Motor
vehicles Land Totals
£    £    £   
COST
At 1 January 2024 270,851 311,035 6,168,847
Additions 38,419 - 1,044,684
Disposals (73,329 ) - (111,029 )
At 31 December 2024 235,941 311,035 7,102,502
DEPRECIATION
At 1 January 2024 239,022 - 4,349,015
Charge for year 14,535 - 290,624
Eliminated on disposal (70,538 ) - (99,039 )
At 31 December 2024 183,019 - 4,540,600
NET BOOK VALUE
At 31 December 2024 52,922 311,035 2,561,902
At 31 December 2023 31,829 311,035 1,819,832

BELL BROTHERS NURSERIES LIMITED (REGISTERED NUMBER: 04331554)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


8. TANGIBLE FIXED ASSETS - continued

Company

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:
Plant and
machinery
£   
COST
At 1 January 2024 542,190
Additions 7,503
Transfer to ownership (90,000 )
Reclassification/transfer 552
At 31 December 2024 460,245
DEPRECIATION
At 1 January 2024 101,566
Charge for year 57,667
Transfer to ownership (25,788 )
Reclassification/transfer 21
At 31 December 2024 133,466
NET BOOK VALUE
At 31 December 2024 326,779
At 31 December 2023 440,624

9. FIXED ASSET INVESTMENTS

Group
Unlisted
investments
£   
COST
At 1 January 2024
and 31 December 2024 3,001
NET BOOK VALUE
At 31 December 2024 3,001
At 31 December 2023 3,001

BELL BROTHERS NURSERIES LIMITED (REGISTERED NUMBER: 04331554)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


9. FIXED ASSET INVESTMENTS - continued

Company
Shares in
group Unlisted
undertakings investments Totals
£    £    £   
COST
At 1 January 2024
and 31 December 2024 900 3,001 3,901
NET BOOK VALUE
At 31 December 2024 900 3,001 3,901
At 31 December 2023 900 3,001 3,901

The group or the company's investments at the Balance Sheet date in the share capital of companies include the following:

Subsidiary

Bell Brothers Farms Limited
Registered office: The Old Vicarage, Church Close, Boston, PE21 6NA
Nature of business: Farming
%
Class of shares: holding
Ordinary 90.00
2024 2023
£    £   
Aggregate capital and reserves (62,557 ) 187
Loss for the year (62,744 ) (47,335 )


10. INVESTMENT PROPERTY

Group
Total
£   
FAIR VALUE
Additions 300,000
At 31 December 2024 300,000
NET BOOK VALUE
At 31 December 2024 300,000

BELL BROTHERS NURSERIES LIMITED (REGISTERED NUMBER: 04331554)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


10. INVESTMENT PROPERTY - continued

Company
Total
£   
FAIR VALUE
Additions 300,000
At 31 December 2024 300,000
NET BOOK VALUE
At 31 December 2024 300,000

11. STOCKS

Group Company
2024 2023 2024 2023
£    £    £    £   
Plant stocks 3,783,284 2,505,528 3,778,762 2,498,684

12. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
2024 2023 2024 2023
£    £    £    £   
Trade debtors 869,443 792,259 848,423 792,259
Amounts owed by group undertakings - - 602,725 587,402
Other debtors 6,378 225,265 6,378 225,265
Directors' current accounts 216,627 70,216 206,627 60,216
Tax 28,568 34,606 28,568 34,606
VAT - 15,192 - 12,926
Called up share capital not paid 100 100 - -
Prepayments and accrued income 307,990 1,567,315 277,450 1,527,041
1,429,106 2,704,953 1,970,171 3,239,715

BELL BROTHERS NURSERIES LIMITED (REGISTERED NUMBER: 04331554)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


13. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
2024 2023 2024 2023
£    £    £    £   
Bank loans and overdrafts (see note 15) 1,516,936 674,350 1,516,936 674,350
Other loans (see note 15) 293,068 139,775 293,068 139,775
Hire purchase contracts (see note 16) 90,279 100,626 90,279 100,626
Trade creditors 1,435,429 1,487,836 1,382,337 1,486,432
Corporation Tax 6,026 - 6,026 -
Social security and other taxes 99,235 32,945 99,235 32,945
VAT 131,339 - 131,888 -
Other creditors 109,682 68,702 89,682 48,702
Directors' current accounts - 71,323 - 71,323
Accruals and deferred income 100,295 57,904 99,200 56,909
3,782,289 2,633,461 3,708,651 2,611,062

14. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

Group Company
2024 2023 2024 2023
£    £    £    £   
Bank loans (see note 15) 2,913,466 1,887,084 2,913,466 1,887,084
Other loans (see note 15) 116,711 266,805 116,711 266,805
Hire purchase contracts (see note 16) 159,292 211,168 159,292 211,168
3,189,469 2,365,057 3,189,469 2,365,057

BELL BROTHERS NURSERIES LIMITED (REGISTERED NUMBER: 04331554)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


15. LOANS

An analysis of the maturity of loans is given below:

Group Company
2024 2023 2024 2023
£    £    £    £   
Amounts falling due within one year or on demand:
Bank overdrafts 1,365,164 555,189 1,365,164 555,189
HSBC Loan 151,772 119,161 151,772 119,161
Other loans 293,068 139,775 293,068 139,775
1,810,004 814,125 1,810,004 814,125
Amounts falling due between one and two years:
HSBC Loan 158,706 123,652 158,706 123,652
Other loans - 1-2 years 68,970 150,094 68,970 150,094
227,676 273,746 227,676 273,746
Amounts falling due between two and five years:
Bank loans - 2-5 years 431,260 360,170 431,260 360,170
Other loans - 2-5 years 47,741 116,711 47,741 116,711
479,001 476,881 479,001 476,881
Amounts falling due in more than five years:
Repayable by instalments
Bank loans more 5 yr by instal 2,323,500 1,403,262 2,323,500 1,403,262

16. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Group
Hire purchase
contracts
2024 2023
£    £   
Net obligations repayable:
Within one year 90,279 100,626
Between one and five years 159,292 211,168
249,571 311,794

BELL BROTHERS NURSERIES LIMITED (REGISTERED NUMBER: 04331554)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


16. LEASING AGREEMENTS - continued

Company
Hire purchase
contracts
2024 2023
£    £   
Net obligations repayable:
Within one year 90,279 100,626
Between one and five years 159,292 211,168
249,571 311,794

Company
Non-cancellable
operating leases
2024 2023
£    £   
Within one year 5,411 4,649
Between one and five years 2,554 775
7,965 5,424

17. SECURED DEBTS

The following secured debts are included within creditors:

Group Company
2024 2023 2024 2023
£    £    £    £   
Bank overdrafts 1,365,164 555,189 1,365,164 555,189
Bank loans 3,065,238 2,006,245 3,065,238 2,006,245
Hire purchase contracts 249,571 311,794 249,571 311,794
4,679,973 2,873,228 4,679,973 2,873,228

18. PROVISIONS FOR LIABILITIES

Group Company
2024 2023 2024 2023
£    £    £    £   
Deferred tax 150,300 105,503 150,300 105,503

BELL BROTHERS NURSERIES LIMITED (REGISTERED NUMBER: 04331554)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


18. PROVISIONS FOR LIABILITIES - continued

Group
Deferred
tax
£   
Balance at 1 January 2024 105,503
Charge to Income Statement during year 44,797
Balance at 31 December 2024 150,300

Company
Deferred
tax
£   
Balance at 1 January 2024 105,503
Charge to Income Statement during year 44,797
Balance at 31 December 2024 150,300

19. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
1,000 Ordinary £1 1,000 1,000

20. RESERVES

Group
Retained
earnings
£   

At 1 January 2024 2,510,084
Deficit for the year (507,196 )
At 31 December 2024 2,002,888

BELL BROTHERS NURSERIES LIMITED (REGISTERED NUMBER: 04331554)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


20. RESERVES - continued

Company
Retained
earnings
£   

At 1 January 2024 2,510,352
Deficit for the year (450,727 )
At 31 December 2024 2,059,625


21. NON-CONTROLLING INTERESTS

The minority interest represents a 10% minority holding in Bell Brothers Farms Limited.

22. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 December 2024 and 31 December 2023:

2024 2023
£    £   
R A Bell
Balance outstanding at start of year 64,399 73,888
Amounts advanced 91,538 -
Amounts repaid - (9,489 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 155,937 64,399

Mr J D Bell
Balance outstanding at start of year - 20,758
Amounts advanced 20,909 -
Amounts repaid - (20,758 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 20,909 -

B D Bell
Balance outstanding at start of year 3,506 -
Amounts advanced 15,463 3,506
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 18,969 3,506

BELL BROTHERS NURSERIES LIMITED (REGISTERED NUMBER: 04331554)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


22. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES - continued

Mrs M A Bell
Balance outstanding at start of year 2,312 -
Amounts advanced 18,500 2,312
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 20,812 2,312

23. SUBSIDIARY

The following subsidiary has taken audit exemption under Section 479A

Bell Brothers Farms Limited Registered Number 07087314.